SBIR/STTR Research Award

Delayed Hydrogel Tissue Expander

Award identifier bb9b61a8344b4de2af8093c121a4b2fdd615d32d5df601c3374cc96ad289881bAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$100,000

Program and phase

SBIR · Phase I

Award year

2007

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
AKINA, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
WTBLC3LE13U1
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): The objective of this Phase I study is to develop novel hydrogel-based tissue expanders that have delayed expansion with the capacity to be reshaped by the surgeon. Currently, plastic surgery routinely uses silicone balloon-type tissue expanders or self-inflating expanders. Balloon-type tissue expanders require multiple visits and exterior equipment to generate expansion. Current self-inflating expanders expand immediately which may damage sutures related to the implantation wound. Neither of these technologies has the capability to be easily reshaped at the time of surgery. Given the wide range of tissue shapes and sizes encountered in the human body, the ability to reshape the expander by the surgeon with scissors and scalpels is desirable. This study will initially focus on expanders for use in dental surgery; however the same principles can be utilized for other tissues. The proposed hydrogel- based tissue expander will utilize biodegradable cross-linkers to delay swelling for 2-3 weeks so that surrounding tissues may heal from implantation prior to expansion. For shaping the proposed expander should also be elastic and flexible. The properties to be optimized in this study will be delayed swelling and flexibility Specific Aim 1 is the synthesis and characterization of biodegradable cross-linkers. These cross-linkers will utilize a biodegradable spacer. The materials used for this spacer chemically react in the presence of water generating non-toxic degradents which are either metabolized or excreted from the human body by a variety of mechanisms. These spacer units will be end-capped with non-degradable cross-linker units which hold the polymer chains of the hydrogel together until degradation occurs, thus slowing the rate of swelling. Specific Aim 2 is the characterization of delayed swelling hydrogels generated using these biodegradable cross-linkers. These cross-linkers will be incorporated into existing hydrogel technology to generate delayed swelling hydrogels. These hydrogels will be tested to determine their swelling pressure, degradability, elastic properties and mechanical properties. Successful completion of this Phase I study will generate novel, delayed-swelling, hydrogel based, tissue expanders which do not suffer the drawbacks of current tissue expansion technologies. These tissue expanders will not swell until sufficient healing has occurred for tissue expansion. These tissue expanders will not require multiple visits utilizing exterior equipment such as pumps and valves. These tissue expanders will also be easily re-shapable by the surgeon to custom fit certain tissues using tools readily available such as scissors. Phase II development will focus on creating a marketable prototype and animal studies. The objective of this research is to generate re-shapable, delayed-expansion, hydrogel-based tissue expanders for use in dental and reconstructive surgery. These tissue expanders will overcome problems associated with current technology such as eliminating exterior equipment and allowing custom fitting of the expander to the tissue by the surgeon. This technology will reduce the incidence of morbidity associated with this surgery thus promoting general public health.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

7 SBIR/STTR records share this UEI (2007–2023). Reported award amounts total $2,191,331. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.